Refine your search
Availability
-
Authors
-
Topics
- Antirheumatic Agents
- Asia
- Australia
- Biological Products
- Biosimilar Pharmaceuticals
- Drug Approval
- Drug Development
- Government Regulation
- Humans
- Patient Safety
- Policy Making
- Practice Guidelines as Topic
- Rheumatic Diseases
- Rheumatology
- Risk Assessment
- Terminology as Topic
- Treatment Outcome
- Tumor Necrosis Factor-alpha
- adverse effects
- antagonists & inhibitors
- Show more
- Show less
-
Languages